- Cat. No.
- A64590
QKY-613
QKY-613 is a cGAS activator designed to enhance immune surveillance through nucleic acid modification pathways. As a prodrug, QKY-613 promotes the incorporation of 6mdA (N6-methyldeoxyadenosine) into viral DNA, which increases the phase separation potential and activates cGAS. In studies using virus-infected mouse models, QKY-613 demonstrated a significant reduction in mortality among aged mice. This compound is valuable for research investigating nucleic acid modification mechanisms and their role in immune response enhancement.